×
戻る Agenda
Session 23: Interactions with FDA - Part 2
Session Chair(s)
Elliott Berger, PhD, MS
President
ETB Regulatory Consulting, United States
- Principles for communicating with FDA
- Meeting etiquette
- Resolving issues or disputes with FDA
- Summary on interacting with FDA
- Advisory committee meetings
- Advisory committee meeting video